The institute seminar on Wednesday April 2nd will was held by the distinguished guest lecturer dr. Paul S. Meltzer, Head of the Molecular Genetics Section and Branch Chief at the Center for Cancer Research, National Cancer Institute, U.S.
Title of his talk: Bringing the New Sequencing Technologies to the Oncology Clinic: Opportunities and Challenges
Published in major journals, first or last author from Oslo University Hospital.
Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial
Lancet, 385 (9978), 1653-61
Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing Cholangitis
Gastroenterology, 148 (5), 924-927.e2
Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma
Hepatology, 61 (5), 1651-9